DOI: 10.36347/sjmcr.2023.v11i03.023

Pages: 339-343

Cerebral venous thrombosis (CVT) is a rare pathology characterized by the diversity of its etiologies and clinical presentation, which are sometimes responsible for diagnostic delays. Basic treatment is curative anticoagulation, usually with heparin. However, direct oral anticoagulants are beginning to have a place in this condition. Prognosis is generally good, even in the presence of an important initial deficit. We report the case of a 20-year-old woman admitted in our intensive care unit for the management of a CVT who did not respond to the treatment associating heparin and thrombectomy and who was treated with rivaroxaban with a good outcome.